Skip to content
Independent analysis of NHS open data
PharmaInsight

Ixekizumab 80mg/1ml solution for injection pre-filled disposable devices

Secondary Care Medicines Data (SCMD) · indicative cost
Data updated April 2026

NHS hospitals in England used £50,162,625 of indicative cost of Ixekizumab 80mg/1ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 6.6% on the previous 12 months.

£50,162,625 +6.6%

Indicative cost · 12 months

44,589units

Quantity (VMP units) · 12 months

0.2%

Share of hospital medicines spend

Figure 1. Ixekizumab 80mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)

£0m £2.4m £4.7m Apr 2021 Jan 2022 Oct 2022 Jul 2023 Apr 2024 Jan 2025 Apr 2026 £4.0m Apr 2021: £1.6m May 2021: £1.6m Jun 2021: £1.8m Jul 2021: £1.9m Aug 2021: £2.0m Sep 2021: £2.1m Oct 2021: £1.8m Nov 2021: £2.3m Dec 2021: £2.0m Jan 2022: £2.7m Feb 2022: £2.3m Mar 2022: £3.3m Apr 2022: £2.0m May 2022: £2.7m Jun 2022: £2.4m Jul 2022: £2.6m Aug 2022: £2.9m Sep 2022: £2.8m Oct 2022: £2.9m Nov 2022: £3.1m Dec 2022: £2.5m Jan 2023: £3.4m Feb 2023: £2.9m Mar 2023: £3.9m Apr 2023: £3m May 2023: £3.2m Jun 2023: £3.5m Jul 2023: £4.0m Aug 2023: £3.7m Sep 2023: £3.8m Oct 2023: £3.6m Nov 2023: £3.7m Dec 2023: £3.1m Jan 2024: £4.1m Feb 2024: £3.5m Mar 2024: £3.3m Apr 2024: £4.1m May 2024: £3.4m Jun 2024: £3.0m Jul 2024: £4.0m Aug 2024: £3.8m Sep 2024: £4.0m Oct 2024: £4.7m Nov 2024: £4.2m Dec 2024: £3.7m Jan 2025: £4.7m Feb 2025: £3.7m Mar 2025: £4.1m Apr 2025: £3.8m May 2025: £3.7m Jun 2025: £4.3m Jul 2025: £4.4m Aug 2025: £4.2m Sep 2025: £4.2m Oct 2025: £4.5m Nov 2025: £4.2m Dec 2025: £4.2m Jan 2026: £4.5m Feb 2026: £3.8m Mar 2026: £4.3m Apr 2026: £4.0m

Source: NHSBSA Secondary Care Medicines Data, to April 2026

Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.

NHS trusts using Ixekizumab 80mg/1ml solution for injection pre-filled disposable devices most

By indicative cost over the 12 months to April 2026.

NHS trusts using Ixekizumab 80mg/1ml solution for injection pre-filled disposable devices most, by indicative cost
NHS trustIndicative cost (12 months)
Guy's & St Thomas' Nhs Foundation Trust £2,927,250
Leeds Teaching Hpls Nhs Trust £2,074,500
North West Anglia Nhs Foundation Trust £1,919,250
Derby Teaching Hospitals Nhs Found Trust £1,875,375
Cambridge Univ Hosp Nhs Foundation Trust £1,859,625
Salford Royal Nhs Foundation Trust £1,746,000
Frimley Health Nhs Foundation Trust £1,251,000
Aintree University Hospital Nhs Ft £1,150,875
King's College Hpl Nhs Foundation Trust £1,132,875
Luton & Dunstable Hospital Trust £1,024,875

The primary-care picture

Ixekizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ixekizumab medicine page.